INFORMUTA, INC.

Medtech · Private

Platform for detecting genetic antibiotic resistance motifs using mutational signatures to predict bacterial drug susceptibility

Grants
$275K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Leveraging Sequencing to Identify and Predict Multidrug Resistance$275,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1047Kestrel Labs Inc——
1048KATHAROS, INC.——
1049BIOSIGHT, LLC——
1050INFORMUTA, INC.——
1051ASC Newcastle LLC—$13M
1052NEONEUR LLC——
1053Peytant Solutions, Inc.—$2.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.